Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability

about

Mefloquine for preventing malaria in pregnant women.

P2860

Q51737259-EC14A4CE-F5A4-4184-90D7-F023C952FE16

P2860

Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability

Item

http://www.wikidata.org/entity/Q35933939

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Mefloquine Versus Sulfadoxine- ...... s on Efficacy and Tolerability

@ast

Mefloquine Versus Sulfadoxine- ...... s on Efficacy and Tolerability

@en

type

Item

label

Mefloquine Versus Sulfadoxine- ...... s on Efficacy and Tolerability

@ast

Mefloquine Versus Sulfadoxine- ...... s on Efficacy and Tolerability

@en

prefLabel

Mefloquine Versus Sulfadoxine- ...... s on Efficacy and Tolerability

@ast

Mefloquine Versus Sulfadoxine- ...... s on Efficacy and Tolerability

@en

P1476

Mefloquine Versus Sulfadoxine- ...... s on Efficacy and Tolerability

@en

P2093

Pascale Tubert-Bitter

http://www.w3.org/2001/XMLSchema#string

Valérie Briand

http://www.w3.org/2001/XMLSchema#string

Valérie Journot

http://www.w3.org/2001/XMLSchema#string

P2860

Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy

Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial

Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.

Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study.

Epidemiology and burden of malaria in pregnancy.

Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance.

High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin

Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting.

P304

300-304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4269/AJTMH.14-0783

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michel Cot

Sylvie Escolano

Achille Massougbodji

P577

2015-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278047011

http://www.w3.org/2001/XMLSchema#string

P698

26055735

http://www.w3.org/2001/XMLSchema#string

P921

pyrimethamine

P932

4530751

http://www.w3.org/2001/XMLSchema#string

Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability

about

P2860

P2860

Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932